Abstract
The intravenous injection of the mast cell degranulator C 48/80 (1 mg/kg) in rats did not produce thrombocytopenia nor circulating platelet aggregates but sensitized the platelets to aggregate upon turbulence challenge. Such turbulence-induced platelet aggregation was not accompanied by formation of thromboxane B2. Electron microscopy revealed absence of platelet degranulation. Turbulence-induced platelet aggregation was completely prevented by pre-treatment of the rats with cyproheptadine, dipyridamole and VK 774, partially with ketanserin (5HT2-receptor antagonist), but not with methysergide (anti-serotonergic drug), pyrilamine (antihistaminic drug), suprofen, aspirin (cyclo-oxygenase inhibitors), phentolamine, propranolol, flunarizine, lidoflazine, oxycoumarin or Trasylol®. Combined treatment with the anti-histaminic drug pyrilamine and the 5HT2-receptor antagonist ketanserin resulted in a dose-related inhibition for ketanserin of the turbulence-induced platelet aggregation. These experiments point to an interaction between histamine and 5-hydroxytryptamine in the platelet activation by mast cell released mediators.
Similar content being viewed by others
References
K.A. Knauer, L.M. Lichtenstein, N.F. Adkinson andJ.E. Fisch,Platelet activation during antigen induced airway reactions in asthmatic subjects, New Engl. J. Med.304, 1404–1407 (1981).
J.L. David andF. De Clerck, Detection of platelet activationin vivo: significance and limitations of the available tests. In5-Hydroxytryptamine in Peripheral Reactions, (Eds.F. De Clerck andP.M. Vanhoutte). Raven Press, New York 1982 (in press).
K.M. McLaren, L. Holloway andD.S. Pepper,Human platelet factor 4 and tissue mast cells, Thromb. Res.12, 293–297 (1980).
G. Cella andA. Girolami,Platelet activation in antigen-induced bronchoconstriction, New Engl. J. Med.305, 842–893 (1981).
B.B. Vargaftig, M. Chignard andJ. Benveniste,Present concepts on the mechanisms of platelet aggregation, Biochem. Pharmac.30, 263–271 (1981).
F. De Clerck andJ.L. David,Pharmacological control of platelet and red blood cell function in the microcirculation, J. Cardiovasc. Pharmac.3, 1388–1412 (1981).
L.M. McManus, C.A. Morley, S.P. Levine andR.N. Pinckard,Platelet activating factor (PAF) induced release of platelet factor 4 (PF 4)in vitro and during IgE anaphylaxis in the rabbit, J. Immun.123, 2835–2841 (1979).
B.B. Vargaftig, M. Chignard, J. Lefort andJ. Benveniste,Platelet-tissue interaction: role of platelet activating factor (PAF-acether), Agents and Actions,10, 502–506 (1980).
H.H. Newball, R.W. Berninger, R.C. Talamo andL.M. Lichtenstein,Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization, J. clin. Invest.64, 457–465 (1979).
N.F. Adkinson, H.H. Newball, S. Findlay, K. Adams andL.M. Lichtenstein,Anaphylactic release of prostaglandins from human lung in vitro, Am. Rev. resp. Dis.121, 911–920 (1980).
F. Sicuteri,Mast cells and their active substances: their role in the pathogenesis of migraine, Headache3, 86–92 (1963).
F. De Clerck, J.L. David andP.A.J. Janssen,Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5HT 2-receptor antagonist, Agents and Actions,12, 388–397, 1982.
B.K. Bhattacharya andG.P. Lewis,The release of 5-hydroxytryptamine by histamine liberators, Br. J. Pharmac.11, 202–208 (1956).
F. Awouters, C.J.E. Niemegeers andP.A.J. Janssen,Inhibition of mast cell-mediated shock in the rat: relationships to histamine and serotonin antagonism, Drug Dev. Res.1, 107–114 (1981).
J.M. Van Nueten, P.A.J. Janssen, J. Van Beek, R. Xhonneux, T. Verbeuren andP.M. Vanhoutte,Vascular effects of ketanserin (R 41 468), a novel antagonist of 5HT 2 serotonergic receptors, J. Pharmac. exp. Thér.218, 217–229 (1981).
J. Hladovec andF. De Clerck,Protection by flunarizine against endothelial cell injury in vitro, Angiology32, 448–462 (1981).
F. De Clerck, L. Van Gorp andR. Xhonneux,Effects of lorcainide, a new antiarrhythmic compound, on the changes in heart rhythm induced by intravenous injection of adenosine-5′-diphosphate in rats, Archs int. Pharmacodyn. Thér.231, 222–231 (1978).
T.S. Burns andR.N. Saunders,Quantitation of in vivo platelet aggregation by the platelet aggregate ratio method, Thromb. Res.10, 629–633 (1977).
F. De Clerck, J. Goossens andR. Reneman,Effects of anti-inflammatory, anticoagulant and vasoactive compounds on tail bleeding time, whole blood coagulation time and platelet retention by glass beads in rats, Thromb. Res.8, 179–193 (1976).
F. De Clerck,Effects of lidoflazine (R 7904) on human platelet function in vitro, Thromb. Diath. haemorrh.28, 228–236 (1972).
J. Caen, M.J. Larrieu andM. Samama,L'Hémostase. Méthodes d'exploration et diagnostique pratique, Expans. Rech. scient., Paris 98–107 (1968).
F. De Clerck, L. Van Gorp, Y. Somers andB. Xhonneux,Effects of ketanserin, a selective 5HT 2-receptor antagonist, on platelet function, plasma coagulation, fibrinolysis and haemostasis in the rat (in preparation, 1982).
F. Geeraerts, L. Schimpfessel andR. Crokaert,A simple routine-method to preserve and determine blood serotonin, Experientia30, 837 (1974).
W.D.M. Patton,Compound 48/80: a potent histamine liberator, Br. J. Pharmac.6, 499–508 (1951).
A. Oliveira, Lima,Pharmacologically active substances released during anaphylactic shock in the mouse, Int. Archs Allergy32, 46–54 (1967).
S.W. Levy andL.B. Jacques,Appearance of heparin antithrombin-active chains in vivo after injection of commercial heparin and in anaphylaxis, Thromb. Res.13, 429–441 (1978).
R.A. Lewis andK.F. Austen,Nonrespiratory functions of pulmonary cells: the mast cell, Fed. Proc.36, 2676–2683 (1977).
B. Humberger, B.B. Fredholm andL.O. Farnebo,Anaphylaxis and plasma catecholamines, Life Sci.26, 1465–1471 (1980).
S.F. Mohammad, W.H. Anderson, J.B. Smith, M.Y.K. Chuang andR.G. Mason,Effects of heparin on platelet aggregation and release and thromboxane A2 production, Am. J. Pathol.104, 132–141 (1981).
P. Zatti,Azione agglutinante dell' istamina sulle piastrine, Boll. Soc. ital. Biol. sper.28, 1034–1035 (1952).
J. Lecomte andY. Bounameaux,Libération d'histamine et agglutination des thrombocytes, Acta allerg.8, 189–197 (1955).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Clerck, F., Somers, Y., Van Gorp, L. et al. Platelet activation by endogenous 5-hydroxytryptamine and histamine released by mast cell degranulation with compound 48/80 in the rat. Agents and Actions 13, 81–87 (1983). https://doi.org/10.1007/BF01994287
Issue Date:
DOI: https://doi.org/10.1007/BF01994287